Your browser doesn't support javascript.
loading
Neoadjuvant Cytoreductive Treatment With BRAF/MEK Inhibition of Prior Unresectable Regionally Advanced Melanoma to Allow Complete Surgical Resection, REDUCTOR: A Prospective, Single-arm, Open-label Phase II Trial.
Blankenstein, Stéphanie A; Rohaan, Maartje W; Klop, Willem Martin C; van der Hiel, Bernies; van de Wiel, Bart A; Lahaye, Max J; Adriaansz, Sandra; Sikorska, Karolina; van Tinteren, Harm; Sari, Aysegül; Grijpink-Ongering, Lindsay G; van Houdt, Winan J; Wouters, Michel W J M; Blank, Christian U; Wilgenhof, Sofie; van Thienen, Johannes V; van Akkooi, Alexander C J; Haanen, John B A G.
Afiliação
  • Blankenstein SA; Department of Surgical Oncology, Netherlands Cancer Institute, Amsterdam, the Netherlands.
  • Rohaan MW; Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, the Netherlands.
  • Klop WMC; Department of Head and Neck Surgery and Oncology, Netherlands Cancer Institute, Amsterdam, the Netherlands.
  • van der Hiel B; Department of Nuclear Medicine, Netherlands Cancer Institute, Amsterdam, the Netherlands.
  • van de Wiel BA; Department of Pathology, Netherlands Cancer Institute, Amsterdam, the Netherlands.
  • Lahaye MJ; Department of Radiology, Netherlands Cancer Institute, Amsterdam, the Netherlands.
  • Adriaansz S; Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, the Netherlands.
  • Sikorska K; Department of Biometrics, Netherlands Cancer Institute, Amsterdam, the Netherlands.
  • van Tinteren H; Department of Biometrics, Princes Máxima Centrum, Utrecht, the Netherlands.
  • Sari A; Department of Biometrics, Netherlands Cancer Institute, Amsterdam, the Netherlands.
  • Grijpink-Ongering LG; Department of Biometrics, Netherlands Cancer Institute, Amsterdam, the Netherlands.
  • van Houdt WJ; Department of Surgical Oncology, Netherlands Cancer Institute, Amsterdam, the Netherlands.
  • Wouters MWJM; Department of Surgical Oncology, Netherlands Cancer Institute, Amsterdam, the Netherlands.
  • Blank CU; Department of Biomedical Data Sciences, Leiden University Medical Center, Leiden, the Netherlands.
  • Wilgenhof S; Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, the Netherlands.
  • van Thienen JV; Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, the Netherlands.
  • van Akkooi ACJ; Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, the Netherlands.
  • Haanen JBAG; Department of Surgical Oncology, Netherlands Cancer Institute, Amsterdam, the Netherlands.
Ann Surg ; 274(2): 383-389, 2021 08 01.
Article em En | MEDLINE | ID: mdl-33843797
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Procedimentos Cirúrgicos de Citorredução / Melanoma Tipo de estudo: Guideline / Observational_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged País como assunto: Europa Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Procedimentos Cirúrgicos de Citorredução / Melanoma Tipo de estudo: Guideline / Observational_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged País como assunto: Europa Idioma: En Ano de publicação: 2021 Tipo de documento: Article